From teledermatology billing to rural outreach and transplant advances, new studies and presentations reveal shifts in access ...

In this Q&A with The American Journal of Managed Care® ( AJMC® ), panelist Turab Mohammed, MD, a hematologist-oncologist at ...

Recent research is helping to expand the potential biomarker landscape in non–small cell lung cancer (NSCLC) and may soon ...

Shawn Davis, MD, a physician at Kelsey-Seybold Clinic specializing in obesity care, addresses why the health care system needs to move beyond body mass index (BMI) as the primary lens for evaluating ...

Proactive adverse effect management helps patients with skin cancer stay on treatment longer, according to Todd Schlesinger, ...

Metabolic dysfunction-associated steatohepatitis (MASH) places a significant burden on the lives of patients, but a proactive ...

Building on insights from last year, experts across sessions at the 2026 American Academy of Dermatology (AAD) Annual Meeting ...

The ongoing disruption in the Middle East is affecting a meaningful portion of global clinical research, with 6.7% of active ...

Overall, mammography prevalence declined from 69.9% to 59.2% among women aged 40 to 49 years and from 81.3% to 77.0% in women ...

The CDC announced on April 1 that they would be downsizing their operations, leading to the pause of diagnostic testing for mpox, rabies, and more than 2 dozen other infectious diseases. 1 The CDC has ...

The FDA proposes MRD negativity as an accelerated approval end point to speed access to novel myeloma therapies.

ATTAIN demonstrated placebo-adjusted weight reductions of roughly 9–11 percentage points at 72 weeks, with 27.3 lb (12.4%) ...